Latest TRVI reports update at 2024-05-07: 2024-Q1 ∙ 2023-Q4 ∙ 2023-Q1

Trevi Therapeutics TRVI

$ 2.92 10.61%

Trevi Therapeutics Financial Statements 2011-2024 | TRVI

Annual Financial Statements Trevi Therapeutics

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	351 M	119 M	14.6 M	55.3 M	93.6 M	-	2.32 B	2.32 B	-	-	-	-	-
Shares	99 M	64.5 M	22.8 M	18.5 M	17.8 M	-	15.4 M	15.4 M	-	-	-	-	-
Historical Prices	3.54	1.84	0.638	2.98	4.98	-	-	-	-	-	-	-	-
Net Income	-29.1 M	-29.2 M	-33.9 M	-32.8 M	-26 M	-20.5 M	-12.9 M	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-33.9 M	-29.9 M	-32.5 M	-32.5 M	-26.6 M	-18.4 M	-	-	-	-	-	-	-
Interest Expense	391 K	1.16 M	1.2 M	456 K	-	174 K	-	-	-	-	-	-	-
EBITDA	-33.8 M	-29.9 M	-32.4 M	-32.3 M	-26.6 M	-20.5 M	-8.19 M	-	-	-	-	-	-
Operating Expenses	33.9 M	29.9 M	32.5 M	32.5 M	26.6 M	-	-	-	-	-	-	-	-
General and Administrative Expenses	10.2 M	10.1 M	9.49 M	10.2 M	7.31 M	4.34 M	2.14 M	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Trevi Therapeutics

	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	99.5 M	68.3 M	99.3 M	98.7 M	98.6 M	59.9 M	68.9 M	59.5 M	30.8 M	28.5 M	21.6 M	20.1 M	19.4 M	18.5 M	18.1 M	17.8 M	17.8 M	17.8 M	17.8 M	10.6 M	444 K	439 K	439 K	439 K	435 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-10.9 M	-	-7.7 M	-7.14 M	-6.4 M	-	-8.27 M	-8.05 M	-7.33 M	-	-7.26 M	-9.79 M	-8.37 M	-	-32.8 M	-32.8 M	-32.8 M	-	-26.1 M	-26.1 M	-26.1 M	-	-20.5 M	-20.5 M	-20.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-11.9 M	-	-9.04 M	-8.38 M	-7.56 M	-	-8.4 M	-7.82 M	-7.02 M	-	-6.95 M	-9.17 M	-8.09 M	-	-7.24 M	-7.41 M	-8.64 M	-	-7.65 M	-7.42 M	-4.81 M	-	-4.96 M	-4.38 M	-3.14 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	1 K	-	3 K	153 K	231 K	-	292 K	295 K	302 K	-	303 K	296 K	294 K	-	148 K	-	-	-	-	-	-	-	174 K	51 K	123 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-11.9 M	-	-	-	-7.54 M	-	-8.38 M	-7.8 M	-7.01 M	-	-6.91 M	-9.14 M	-8.08 M	-	-7.21 M	-7.39 M	-8.63 M	-	-7.62 M	-7.4 M	-4.8 M	-	-4.95 M	-4.37 M	-3.14 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	11.9 M	-	9.04 M	8.38 M	7.56 M	-	8.4 M	7.82 M	7.02 M	-	6.95 M	9.17 M	8.09 M	-	7.24 M	7.41 M	8.64 M	-	7.65 M	7.42 M	4.81 M	-	4.96 M	4.38 M	3.14 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	3.1 M	-	2.72 M	2.54 M	2.56 M	-	2.64 M	2.72 M	2.38 M	-	2.23 M	2.67 M	2.5 M	-	2.42 M	2.49 M	2.62 M	-	2 M	1.89 M	1.47 M	-	1.21 M	941 K	779 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency